Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Charge Enterprises And 3 Other Stocks Under $1 Insiders Are Buying

Published 13/09/2023, 13:57
© Reuters.  Charge Enterprises And 3 Other Stocks Under $1 Insiders Are Buying

Benzinga - by Lisa Levin, Benzinga Editor.

The Dow Jones closed slightly lower on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

Vivani Medical

  • The Trade: Vivani Medical, Inc. (NASDAQ: VANI) Director Gregg Williams acquired a total of 13,997 shares an average price of $0.95. To acquire these shares, it cost around $13,279.
  • What’s Happening: Vivani Medical posted a wider-than-expected quarterly loss.
  • What Vivani Medical Does: Vivani Medical Inc is a preclinical stage biopharmaceutical company. It develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near constant-rate delivery of a broad range of medicines to treat chronic diseases.
Pacific Health Care Organization
  • The Trade: Pacific Health Care Organization, Inc. (OTC: PFHO) CEO and President Tom Kubota acquired a total of 54,047 shares at an average price of $0.82. The insider spent around $44,319.
  • What’s Happening: The company reported net income of $176,427 or $0.01 per share for the three months ended June 30, 2023.
  • What Pacific Health Care Organization Does: Pacific Health Care Organization Inc is a specialty workers' compensation managed care company. The company serves any size employer in the state of California as well as insurers, third-party administrators, self-administered employers, municipalities and other industries.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
Charge Enterprises
  • The Trade: Charge Enterprises, Inc. (NASDAQ: CRGE) Director Philip Scala acquired a total of 44,000 shares at an average price of $0.48. To acquire these shares, it cost around $21,120.
  • What’s Happening: Charge Enterprises named COO Craig Denson as interim CEO and lead independent director Amy Hanson as Chair effective Aug. 31, after Andrew Fox resigned.
  • What Charge Enterprises Does: Charge Enterprises Inc is an electrical, broadband, and electric vehicle (EV) charging infrastructure company that provides clients with end-to-end project management services, from advising, designing, engineering, acquiring, and installing equipment, to monitoring, servicing, and maintenance.

Don’t forget to check out our premarket coverage here

Bone Biologics

  • The Trade: Bone Biologics Corporation (NASDAQ: BBLG) CEO Jeff Frelick acquired a total of 9,500 shares at an average price of $0.69. The insider spent $ $6,530 to buy those shares.
  • What’s Happening: Bone Biologics priced its public offering of 2.54 million shares at $1.97 per share.
  • What Bone Biologics Does: Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.